항정신병약물악성증후군에 동반한 횡문근융해증으로 인한 급성 신부전 1례 = A Case of Acute Renal Failure due to Rhabdomyolysis Associated with Neuroleptic Malignant Syndrome

국문 초록 (Abstract)

항정신병약물악성증후군은 항정신병약물의 사용과 관련하여 드물게 발생하는 부작용으로 생명을 위협하는 질환으로 의식변화, 고열증, 근육강직의 특징적 증상을 보인다. 항정신병약물악성증후군 환자에서 고열증과 근육강직으로 인하여 횡문근융해증이 발생하여 합병증으로 급성 신부전이 생기는 경우가 드물게 발생하며 심한 경우 투석 등의 치료가 필요하며 생명에 위협이 되므로 빠른 진단과 치료가 요구된다. 저자들은 소아에서 보고되지 않던 항정신병약물악성증후군에 동반하여 횡문근융해증을 보인 급성 신부전의 예를 경험하였기에 보고하는 바이다.

다국어 초록 (Multilingual Abstract)

Neuroleptic malignant syndrome (NMS) is a rare, but a potentially life threatening condition associated with the use of antipsychotics. The most frequent signs and symptoms of NMS include fever, muscle rigidity, autonomic dysfunction such as tachycardia, tachypnea, and labile blood pressure. Acute complications of NMS include disseminated intravascular coagulation, sepsis, seizure, myocardial infarction, acute renal failure due to rhabdomyolysis and death. We report a rare case of acute renal failure due to rhabdomyolysis associated with neuroleptic malignant syndrome.

참고문헌 (Reference)

1 Addonizio G, "Symptoms of neuroleptic malignant syndrome in 82 consecutive inpatients" 143 : 1587-1590, 1986

2 Sanai T, "Successful treatment of six patients with neuroleptic malignant syndrome associated with myoglobulinemic acute renal failure" 28 : 51-55, 2006

3 Watanabe T, "Rhabdomyolysis and acute renal failure in children" 16 : 1072-1075, 2001

4 Lazzarin M, "Rhabdomyolysis and acute renal failure caused by haloperidol-decanoate(neuroleptic malignant syndrome)" 87 : 422-424, 1996

5 Vanholder R, "Rhabdomyolysis" 11 : 553-556, 2000

6 Zaqer RA, "Pathogenesis mechanisms in experimental hemoglobinuria acute renal failure" 256 : 446-455, 1989

7 Sandhu JS, "Non-traumatic rhabdomyolysis with acute renal failure" 22 : 81-86, 2000

8 Woodury MM, "Neuroleptic- induced catatonia as a stage in the progression toward neuroleptic malignant syndrome" 31 : 1161-1164, 1992

9 Pope HG Jr, "Neuroleptic malignant syndrome: long-term follow-up of 20 cases" 52 : 208-212, 1991

10 Chandran Gj, "Neuroleptic malignant syndrome: case report and discussion" 169 : 439-442, 2003

11 Caroff SN, "Neuroleptic malignant syndrome. In: Neuroleptic Malignant Syndriome and Related Condition. 2nd ed" American Psychiatric Publishing 1-44, 2003

12 Trollor JN, "Neuroleptic malignant syndrome associated with atypical antipsychotic drugs" 23 : 477-492, 2009

13 Harrison PA, "Neuroleptic malignant syndrome" 108 : 35-38, 2008

14 Strawn JR, "Neuroleptic malignant syndrome" 164 : 870-876, 2007

15 Caroff SN, "Neuroleptic malignant syndrome" 77 : 185-202, 1993

16 Kipps CM, "Movement disorder emergencies" 20 : 322-334, 2005

17 Andreassen MD, "Malignant neuroleptic syndrome. A review of epidemiology, risk factors, diagnosis, differential diagnosis and pathogenesis of MNS" 162 : 1366-1370, 2000

18 Brunelle J, "Aripitrazole and neuroleptic malignant syndrome" 27 : 212-214, 2007

19 Sulowicz W, "Acute renal failure in patients with rhabdomyolysis" 8 : 24-27, 2002

20 Mannix R, "Acute pediatric rhabdomyolysis: causes and rates of renal failure" 118 : 2119-2125, 2006